| Value | ₹0.05 Cr |
|---|
BSE filing, BSE: 544778. Summary written from the filing by ALFA Finder's alert engine.
Vahh Chemicals Ltd: key numbers
- Share price
- ₹43.90
- Market cap
- ₹36.46 Cr
- Revenue (annual)
- ₹43.15 Cr
- Net profit (annual)
- ₹4.81 Cr
- P/E (TTM)
- 7.6×Sector 34.1×
- Promoter holding
- 64.63%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vahh Chemicals Ltd
All →Vahh Chemicals Board Meeting Date
Vahh Chemicals will hold a board meeting on October 31, 2026, to consider and approve the standalone and consolidated unaudited financial results.
Vahh Chemicals Other Announcement
Vahh Chemicals Limited submitted a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming that all shares remained in dematerialized form for the quarter.
Vahh Chemicals Management Change
Mrs. Shivani Parth Kothari has resigned as the Company Secretary and Compliance Officer of Vahh Chemicals Limited. Her resignation became effective on September 30, 2026.
Vahh Chemicals Annual General Meeting
Vahh Chemicals Ltd held its Extraordinary General Meeting on August 13, 2026. Shareholders transacted the business of approving the appointment of Statutory Auditors to fill a casual vacancy.
Vahh Chemicals Capacity Expansion: ₹0.25 Cr Investment
Vahh Chemicals Limited has launched a new Digital Printing Chemicals business vertical. The company plans an initial investment of ₹0.25 Crore to develop textile printing solutions.
- Value
- ₹0.25 Cr
Vahh Chemicals Annual General Meeting
Vahh Chemicals Ltd issued a notice for an Extra-ordinary General Meeting on August 13, 2026. The meeting aims to appoint new Statutory Auditors.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr